Materials and methods
The JWP conducted a Literature Review about healthcare pricing models. The JWP also commissioned a project to undertake a clinician-led process to identify, specify, and group a national set of high-priority Hospital-Acquired Complications, in order to facilitate routine local reporting and review. The project included three key activities:
1. A review of safety literature and of reports from hospital incident reporting systems; 2. A clinician-led and iterative identification of highpriority complications; and 3. An analysis of identified complications that used hospital inpatient morbidity data to support clinician-identified complications.
Finally, the JWP assessed the impact of removing Hospital-Acquired Complications from DRG assignment. Its analysis of the existing administrative datasets for admitted patients demonstrated that a Hospital-Acquired Complication is reported for about 10% of patients.
Results
The literature review revealed that a rich literature exists that argues these models should reward quality and safety and many of the arguments in the literature are inherently appealing. While strong in their arguments, however, we found that most of the literature is weak on evidence.
The review project identified 39 high-priority preventable complications, 37 of which can be measured in the existing patient diagnosis datasets using the Condition On-Set Flag. The JWP subsequently launched a sixmonth proof-of-concept project to test this set of preventable complications' utility at the hospital level.
The JWP found that a Hospital-Acquired Complication diagnosis costs around A$9,000 per episode, and increases the patient's length of stay by approximately 5 days. The impact of ignoring these diagnoses in DRG assignment is much smaller, however, with only 3.1% of cases impacted.
